Correlation Between Pmv Pharmaceuticals and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Molecular Partners AG, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Molecular Partners.
Diversification Opportunities for Pmv Pharmaceuticals and Molecular Partners
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Pmv and Molecular is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Molecular Partners go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Molecular Partners
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Molecular Partners. But the stock apears to be less risky and, when comparing its historical volatility, Pmv Pharmaceuticals is 2.33 times less risky than Molecular Partners. The stock trades about -0.22 of its potential returns per unit of risk. The Molecular Partners AG is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 508.00 in Molecular Partners AG on October 21, 2024 and sell it today you would earn a total of 48.00 from holding Molecular Partners AG or generate 9.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Molecular Partners AG
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Molecular Partners |
Pmv Pharmaceuticals and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Molecular Partners
The main advantage of trading using opposite Pmv Pharmaceuticals and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen | Pmv Pharmaceuticals vs. Anebulo Pharmaceuticals |
| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |